Table 2. Study-Wide Significant Gene-Based Test Results .
APOE ε4 Group | Chr | Start | End | Gene | SNV Influence | Modela | No. Variants | cMAC | Sentinel Variant | No. | P Value |
---|---|---|---|---|---|---|---|---|---|---|---|
With ε4 | 11 | 124,134,751 | 124,135,752 | OR8G5 | High + moderate | 2 | 3 | 267 | rs200328143 | 3082 | 4.67 × 10−7 |
14 | 106,518,415 | 106,518,824 | IGHV3-7 | All | 2 | 4 | 11 | rs188349361 | 2870 | 9.75 × 10−16 | |
20 | 19,261,606 | 19,261,724 | SLC24A3 | All | 2 | 2 | 68 | rs3790174 | 3082 | 2.67 × 10−12 | |
Without ε4 | 6 | 41,126,505 | 41,130,815 | TREM2 | High + moderate | 1 | 14 | 310 | rs75932628 | 6656 | 2.75 × 10−8 |
Abbreviations: Chr, chromosome; cMAC, cumulative minor allele count; SNV, single-nucleotide variant.
Model 1: adjusted only for principal components; model 2, adjusted for age, sex, and principal components.